Aldorin - 50mg

Tablet

Pack Size : 10 Tablet x 1 Strip

Generics : Epalrestat

Manufacturer : Eskayef Pharmaceuticals Ltd.

Best Price * TK 80.00

* Delivery will be done in Dhaka city only.

Alternative Product

More Information About - Aldorin - 50mg

Description

Generic Name

Epalrestat

Precaution

Urine may turn yellowish brown or reddish after taking the medicine, because the yellowish brown or reddish color is attributed to components of this medicine.

Indication

Diabetic neuropathy

Contra Indication

Hypersensitivity. Pregnant or breastfeeding.

Dose

N/A

Side Effect

The most commonly reported adverse reactions include abdominal pain, nausea, rash, itch, erythema and blister.

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

Epalrestat is aldose reductase inhibitor. The aldose reductase inhibitors have a distinct mechanism of action, affecting the underlying disease process in diabetic neuropathy, although the extent of the polyol pathway involvement is yet to be determined. Epalrestat reduces sorbitol accumulation in the sciatic nerve, erythrocytes. Epalrestat may improve motor and sensory nerve conduction velocity and subjective neuropathy symptoms.

Interaction

N/A

Pregnancy Category Note

N/A

Adult Dose

Oral Diabetic neuropathy Adult: 50 mg tid.

Child Dose

N/A

Renal Dose

N/A

Administration

N/A

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.